|
|
||||||||

* Department of Virology and World Health Organization National Influenza Center, Erasmus Medical Center, Rotterdam, The Netherlands; and
Sanquin Bloodbank Rotterdam, Laboratory for Histocompatibility and Immunogenetics, Dordrecht, The Netherlands
To study whether individual HLA class I alleles are used preferentially or equally in human virus-specific CTL responses, the contribution of individual HLA-A and -B alleles to the human influenza virus-specific CTL response was investigated. To this end, PBMC were obtained from three groups of HLA-A and -B identical blood donors and stimulated with influenza virus. In the virus-specific CD8+ T cell population, the proportion of IFN-
- and TNF-
-producing cells, restricted by individual HLA-A and -B alleles, was determined using virus-infected C1R cells expressing a single HLA-A or -B allele for restimulation of these cells. In HLA-B*2705- and HLA-B*3501-positive individuals, these alleles were preferentially used in the influenza A virus-specific CTL response, while the contribution of HLA-B*0801 and HLA-A*0101 was minor in these donors. The magnitude of the HLA-B*0801-restricted response was even lower in the presence of HLA-B*2705. C1R cells expressing HLA-B*2705, HLA-A*0101, or HLA-A*0201 were preferentially lysed by virus-specific CD8+ T cells. In contrast, the CTL response to influenza B virus was mainly directed toward HLA-B*0801-restricted epitopes. Thus, the preferential use of HLA alleles depended on the virus studied.
This article has been cited by other articles:
![]() |
A. Palikhe, M.-L. Lokki, P. Saikku, M. Leinonen, M. Paldanius, M. Seppanen, V. Valtonen, M. S. Nieminen, and J. Sinisalo Association of Chlamydia pneumoniae Infection with HLA-B*35 in Patients with Coronary Artery Disease Clin. Vaccine Immunol., January 1, 2008; 15(1): 55 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Wojcechowskyj, L. J. Yant, R. W. Wiseman, S. L. O'Connor, and D. H. O'Connor Control of Simian Immunodeficiency Virus SIVmac239 Is Not Predicted by Inheritance of Mamu-B*17-Containing Haplotypes J. Virol., January 1, 2007; 81(1): 406 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. M. Boon, G. de Mutsert, R. A. M. Fouchier, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan The Hypervariable Immunodominant NP418-426 Epitope from the Influenza A Virus Nucleoprotein Is Recognized by Cytotoxic T Lymphocytes with High Functional Avidity. J. Virol., June 1, 2006; 80(12): 6024 - 6032. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bihl, N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. Impact of HLA-B Alleles, Epitope Binding Affinity, Functional Avidity, and Viral Coinfection on the Immunodominance of Virus-Specific CTL Responses J. Immunol., April 1, 2006; 176(7): 4094 - 4101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |